ASSESSMENT OF THE EFFECTIVENESS OF THE CLINICAL AND PHARMACOECONOMIC ASPECTS OF TOPAMAX IN PATIENTS WITH EPILEPSY. ReFocus [Internet]. 2023 Jun. 5 [cited 2026 Sep. 11];2(5):198-202. Available from: https://refocus.uz/index.php/rf/article/view/247